17/5/2021: We are delighted to announce that RxReasoner has been selected as a participant of the EIT Health Bridgehead Europe.
This prestigious programme brings together the best-in-class health care innovators, who want to grow their business beyond their home market, with the world’s top incubators and accelerators. In the following months, we will plan together how to access new markets quickly and decisively, tap into local networks of partners and clients and understand new regulatory systems.
There’s no risk-free way to enter a new market. Possible challenges range from complex regulatory processes to identifying the right collaborators. Businesses that are able to minimize these risks and challenges can reap serious rewards. RxReasoner will exploit the Bridgehead programme opportunity to foresee upcoming barriers and find the most suitable local experts and partners to successfully mitigate them.
EIT Health contributes an important piece to the european expansion efforts of RxReasoner. Its valuable services will help our team find the pros and cons of each market and decide where to put its efforts.
About Bridgehead Europe
EIT Health’s Bridgehead matches mature scale-ups with incubators, accelerators or clusters from a carefully selected network to help them understand and access new markets quickly and decisively.
About EIT Health
The European Institute of Innovation and Technology is devoted to promote entrepreneurship and develop innovations in healthy living and active ageing, providing Europe with new opportunities and resources. EIT Health will enable citizens to lead healthier and more productive lives by delivering products, services and concepts that will improve quality of life and contribute to the sustainability of healthcare across Europe.
Find out More
RxReasoner - Leading the way to safer medication
Bridgehead announces first start-ups for 2021
